Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pediatric renal transplantation under FK 506 immunosuppression.

Literature DB >> 1721364

Pediatric renal transplantation under FK 506 immunosuppression.

C W Jensen¹, M L Jordan, F X Schneck, R Shapiro, A Tzakis, T R Hakala, T E Starzl.

Abstract

Entities: Chemical

Mesh：

Substances：
Tacrolimus

Year: 1991 PMID： 1721364 PMCID： PMC2968708

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

9 in total

Review 1. Cyclosporine.

Authors: B D Kahan
Journal: N Engl J Med Date: 1989-12-21 Impact factor: 91.245

2. The side effects of FK 506 in humans.

Authors: R Shapiro; J J Fung; A B Jain; P Parks; S Todo; T E Starzl
Journal: Transplant Proc Date: 1990-02 Impact factor: 1.066

3. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Authors: T Kino; H Hatanaka; S Miyata; N Inamura; M Nishiyama; T Yajima; T Goto; M Okuhara; M Kohsaka; H Aoki
Journal: J Antibiot (Tokyo) Date: 1987-09 Impact factor: 2.649

4. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

Authors: T Kino; H Hatanaka; M Hashimoto; M Nishiyama; T Goto; M Okuhara; M Kohsaka; H Aoki; H Imanaka
Journal: J Antibiot (Tokyo) Date: 1987-09 Impact factor: 2.649

5. Five years' experience with cyclosporine in children.

Authors: S B Conley; R J Portman; J M Lemire; C T Van Buren; R Lewis; B D Kahan
Journal: Transplant Proc Date: 1988-06 Impact factor: 1.066

6. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors: J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal: Nature Date: 1989-10-26 Impact factor: 49.962

7. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.

Authors: M W Harding; A Galat; D E Uehling; S L Schreiber
Journal: Nature Date: 1989-10-26 Impact factor: 49.962

8. The use of cadaver kidneys for transplantation in young children.

Authors: S K So; K Gillingham; M Cook; S M Mauer; A Matas; T E Nevins; B M Chavers; J S Najarian
Journal: Transplantation Date: 1990-12 Impact factor: 4.939

9. Kidney transplantation under FK 506.

Authors: T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal: JAMA Date: 1990-07-04 Impact factor: 56.272

9 in total

1. Two-year experience with FK 506 in pediatric patients.

Authors: A G Tzakis; J Reyes; S Todo; B Nour; R Shapiro; M Jordan; J McCauley; J Armitage; J J Fung; T E Starzl
Journal: Transplant Proc Date: 1993-02 Impact factor: 1.066

2. Tacrolimus in pediatric renal transplantation.

Authors: R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; D Ellis; N Gilboa; S Lombardozzi-Lane; W Irish; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal: Transplantation Date: 1996-12-27 Impact factor: 4.939

3. Pediatric renal transplantation under tacrolimus-based immunosuppression.

Authors: R Shapiro; V P Scantlebury; M L Jordan; C Vivas; D Ellis; S Lombardozzi-Lane; N Gilboa; H A Gritsch; W Irish; J McCauley; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal: Transplantation Date: 1999-01-27 Impact factor: 4.939

Review 4. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.

Authors: Agnieszka Swiatecka-Urban
Journal: Paediatr Drugs Date: 2003 Impact factor: 3.022